EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Synthesis of Neuraminidase‐Resistant Sialyllactose Mimetics from N ‐Acyl Mannosamines using Metabolically Engineered Escherichia coli

Paul Rivollier, Eric Samain, Sylvie Armand, Isabelle Jeacomine, Emeline Richard, Sébastien Fort

Chemistry – A European Journal · 2023

DOI: 10.1002/chem.202301555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Paul Rivollier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France. Hauptthemen laut MEDLINE: Lactose, Neuraminidase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we describe the efficient gram‐scale synthesis of α2,3‐ and α2,6‐sialyllactose oligosaccharides as well as mimetics from N ‐acyl mannosamines and lactose in metabolically engineered bacterial cells grown at high cell density. We designed new Escherichia coli strains co‐expressing sialic acid synthase and N ‐acylneuraminate cytidylyltransferase from Campylobacter jejuni together with the α2,3‐sialyltransferase from Neisseria meningitidis or the α2,6‐sialyltransferase from Photobacterium sp. JT‐ISH‐224. Using their mannose transporter, these new strains actively internalized N ‐acetylmannosamine (ManNAc) and its N‐ propanoyl ( N ‐Prop) , N‐ butanoyl ( N ‐But) and N‐ phenylacetyl ( N ‐PhAc) analogs and converted them into the corresponding sialylated oligosaccharides, with overall yields between 10 % and 39 % (200‐700 mg.L −1 of culture). The three α2,6‐sialyllactose analogs showed similar binding affinity for Sambucus nigra SNA−I lectin as for the natural oligosaccharide. They also proved to be stable competitive inhibitors of Vibrio cholerae neuraminidase. These N‐ acyl sialosides therefore hold promise for the development of anti‐adhesion therapy against influenza viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoseNeuraminidaseEscherichia coliSialyltransferasesOligosaccharidesSialic AcidsHexosamines

Stichwörter der Autor:innen

Escherichia coliinfluenza virusinhibitorsmetabolic engineeringsialyllactose

Substanzen

LactoseNeuraminidaseSialyltransferasesOligosaccharidesN-acetylneuraminoyllactoseSialic AcidsmannosamineHexosamines

Autor:innen und Institutionen

  • Univ. Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Rivollier, P., Samain, E., Armand, S., Jeacomine, I., Richard, E., & Fort, S. (2023). Synthesis of Neuraminidase‐Resistant Sialyllactose Mimetics from N ‐Acyl Mannosamines using Metabolically Engineered Escherichia coli. Chemistry – A European Journal. https://doi.org/10.1002/chem.202301555

Vancouver

Rivollier P, Samain E, Armand S, Jeacomine I, Richard E, Fort S. Synthesis of Neuraminidase‐Resistant Sialyllactose Mimetics from N ‐Acyl Mannosamines using Metabolically Engineered Escherichia coli. Chemistry – A European Journal. 2023. doi:10.1002/chem.202301555

BibTeX
@article{Rivollier2023,
  author = {Rivollier, Paul and Samain, Eric and Armand, Sylvie and Jeacomine, Isabelle and Richard, Emeline and Fort, Sébastien},
  title = {Synthesis of Neuraminidase‐Resistant Sialyllactose Mimetics from N ‐Acyl Mannosamines using Metabolically Engineered Escherichia coli},
  journal = {Chemistry – A European Journal},
  year = {2023},
  doi = {10.1002/chem.202301555}
}
Kostenlos starten →